Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBRNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBRNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBRNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DJ.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DJ.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AZ.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AZ.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.193NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.193NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.193NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BL.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BL.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FP.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FP.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.68 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.68 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.68 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.16.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.16.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.16.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DN.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DN.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.5.2 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.5.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.5.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DN.1.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DN.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.1.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.84 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.84 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used